Early administration of broadly neutralizing antibodies in a macaque SHIV infection model is associated with very low levels of persistent viraemia, which leads to the establishment of T-cell immunity and resultant long-term infection control.
- Yoshiaki Nishimura
- Rajeev Gautam
- Malcolm A. Martin